SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2004 • Large Scale Biology Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2004 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 8, 2004, among Large Scale Biology Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and
COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of Large Scale Biology CorporationSecurity Agreement • March 30th, 2004 • Large Scale Biology Corp • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2004 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the day beginning six months after the date of the Purchase Agreement (the “Initial Exercise Date”) and on or prior to the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Large Scale Biology Corporation, a Delaware corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $2.381, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwis
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 30th, 2004 • Large Scale Biology Corp • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2004 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of March 8, 2004, by and among Large Scale Biology Corporation, a Delaware corporation (the “Company”), and the purchasers signatory hereto (each such purchaser, a “Purchaser” and collectively, the “Purchasers”).